Summary
- Revenue
- BPMC current annual revenue is $508.82M, up +104.04% year-over-year
- Next Earnings
- As of today, the next earnings release for BPMC has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Blueprint Medicines Corporation |
| Ticker | NASDAQ: BPMC |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | blueprintmedicines.com |
| Employees | 682 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | - | |
| Price, 1D Change | - | |
| - | ||
| - | ||
| - | ||
| - | N/A | |
| $508.82M | ||
| Revenue, 1Y Change | +104.04% | |
| -$1.07 | ||
| EPS, 1Y Change | +87.25% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$1.07 | ||
| EPS Estimate | -$0.71 | N/A |
| EPS Est. Change | +33.33% | N/A |
| $508.82M | ||
| Revenue Estimate | $723.30M | N/A |
| Revenue Est. Change | +42.15% | N/A |
| Current Price | - | |
| Price Target | $129.00 | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$8.58 | -$8.37 | +2.43% | |
| -$1.37 | -$1.07 | +22.04% | |
| -$0.71 | N/A | +33.33% | |
| $1.15 | N/A | +207.75% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $244.80M | $249.38M | +1.87% | |
| $507.90M | $508.82M | +0.18% | |
| $723.30M | N/A | +42.15% | |
| $1.02B | N/A | +99.50% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | - | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $508.82M | ||
| -$1.07 | ||
| $472.37M | ||
| 92.84% | ||
| -$212.04M | ||
| -41.67% | ||
| -$67.09M | ||
| -13.19% | ||
| $19.23M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 2.43 | ||
| 2.85 | ||
| 2.80 | ||
| - | ||
| 3 | ||
| - |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $298.67M | ||
| $102.01M | ||
| $1.18B | ||
| $742.68M | ||
| $881.15M | ||
| $260.80M | ||
| $724.28M | ||
| $57.26M | ||
| $6.79M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $720.87M | ||
| $700.71M | ||
| $36.45M | ||
| $359.27M | ||
| $16.29M | ||
| $0.00 | ||
| $1.23M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$192.59M | ||
| -$47.50M | ||
| $273.11M | ||
| $4.63M | ||
| -$197.22M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Wells Fargo | → | |
| UBS | → | |
| Morgan Stanley | → | |
| Citigroup | → | |
| Wolfe Research | → | |
| JMP Securities | → | |
| Wedbush | → | |
| Scotiabank | → | |
| Needham | → | |
| JP Morgan | → |
Analyst sentiment
Institutional ownership
Screeners with BPMC
FAQ
- What is the ticker symbol for Blueprint Medicines Corporation?
- The ticker symbol for Blueprint Medicines Corporation is NASDAQ:BPMC
- Does Blueprint Medicines Corporation pay dividends?
- No, Blueprint Medicines Corporation does not pay dividends
- What sector is Blueprint Medicines Corporation in?
- Blueprint Medicines Corporation is in the Healthcare sector
- What industry is Blueprint Medicines Corporation in?
- Blueprint Medicines Corporation is in the Biotechnology industry
- What country is Blueprint Medicines Corporation based in?
- Blueprint Medicines Corporation is headquartered in United States
- When did Blueprint Medicines Corporation go public?
- Blueprint Medicines Corporation initial public offering (IPO) was on April 30, 2015
- Is Blueprint Medicines Corporation in the S&P 500?
- No, Blueprint Medicines Corporation is not included in the S&P 500 index
- Is Blueprint Medicines Corporation in the NASDAQ 100?
- No, Blueprint Medicines Corporation is not included in the NASDAQ 100 index
- Is Blueprint Medicines Corporation in the Dow Jones?
- No, Blueprint Medicines Corporation is not included in the Dow Jones index
- When was Blueprint Medicines Corporation last earnings report?
- Blueprint Medicines Corporation's most recent earnings report was on July 31, 2025
- When does Blueprint Medicines Corporation report earnings?
- The date for Blueprint Medicines Corporation's next earnings report has not been announced yet
Data Sources & References
- BPMC Official Website www.blueprintmedicines.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1597264/000155837025006108/0001558370-25-006108-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1597264/000155837025000953/0001558370-25-000953-index.htm
- BPMC Profile on Yahoo Finance finance.yahoo.com/quote/BPMC
- BPMC Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bpmc